BioSpace News Archive

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced its recognition of National Health Center Week from August 9-15, honoring 30 participating community health centers (CHCs),

Shineco, Inc. announced that the Company’s common stock will trade on a split-adjusted basis following the implementation of a reverse stock split at the ratio of one-for-nine shares on The Nasdaq Capital Market effective with the open of the market on Monday, August 17, 2020.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced the commencement of a proposed underwritten public offering of shares of its common stock.

Precision Optics Corporation, Inc. (OTCQB: PEYE), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced preliminary revenue for the fourth quarter and fiscal year end 2020, ended June 30, 2020.

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced the appointment of Sarah O’Dowd as an independent director to the Protagonist Board of Directors. Ms. O’Dowd brings broad experience in management and corporate governance to Protagonist, including senior level oversight in the biopharmaceutical industry. In connection w

9 Meters Biopharma, Inc. today announced that the Executive Management team will participate in the Prepping ahead of Data Conference Call Series hosted by hosted by Srikripa Devarakonda, PhD and Robyn Karnauskas, PhD

Company Received Over $17.5 Million Net Proceeds from PH94B Upfront License Payment and Public Offering of Common Stock Subsequent to Quarter-end Positive Meeting with the FDA Sets Key Aspects of Pivotal PH94B Phase 3 Study [13-August-2020] SOUTH SAN FRANCISCO, Calif. , Aug. 13, 2020 /PRNewswire/ -- VistaGen Therapeutics, Inc. (Nasdaq: VTGN), a biopharmaceut

Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2020. Results are presented in Canadian dollars unless otherwise noted.

Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the second quarter and for the six months ended June 30, 2020.

Equillium, Inc. announced the pricing of an underwritten public offering of 5,000,000 shares of common stock at a public offering price of $7.00 per share.